Showing results (121-130 of 270) with videos related to

Sort By:
Pageof 27
NPJ Breast Cancer|November 26, 2025
Real-world outcomes of early-stage HER2-positive breast cancer patients treated with adjuvant paclitaxel and trastuzumabGiorgio Bonomi, Gaia Griguolo, Tommaso Giarratano, et al.
NPJ Breast Cancer|October 13, 2021
Evolution of HER2-low expression from primary to recurrent breast cancerFederica Miglietta, Gaia Griguolo, Michele Bottosso, et al.
Cancer|August 12, 2004
Concomitant versus sequential administration of epirubicin and paclitaxel as first-line therapy in metastatic breast carcinoma: results for the Gruppo Oncologico Nord Ovest randomized trialPier Franco Conte, Valentina Guarneri, Paolo Bruzzi, et al.
British Journal of Cancer|September 29, 2022
Longitudinal liquid biopsy anticipates hyperprogression and early death in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitorsElisabetta Zulato, Paola Del Bianco, Giorgia Nardo, et al.
Lung Cancer (Amsterdam, Netherlands)|April 17, 2026
Dissecting the prognostic role of metabolic markers in lung neuroendocrine Tumors: The MONET studyGiulia Pasello, Giulia Pigato, Cristiana Mulargiu, et al.
Cancer Treatment Reviews|June 1, 2014
Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trialsEmilio Bria, Luisa Carbognin, Jenny Furlanetto, et al.
Future Oncology (London, England)|April 9, 2024
Study design for DESTINY-Breast Respond HER2-low Europe: T-DXd in patients with HER2-low advanced breast cancerValentina Guarneri, José Luís Passos Coelho, Francois P Duhoux, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 19, 2025
Baseline levels and dynamic changes of cfDNA, tumor fraction and mutations to anticipate the clinical course of small cell lung cancer (SCLC) patients treated with first-line atezolizumab and chemotherapy: an hypothesis generating study (CATS/ML43257)Giulia Pasello, Giulia Pigato, Daniela Scattolin, et al.
Pathologica|April 9, 2026
Immunohistochemical and molecular profiling of uveal melanoma: clinicopathological correlations from an Italian cohortFrancesco Fortarezza, Giovanni Zarrilli, Giada Munari, et al.
NPJ Breast Cancer|February 13, 2021
Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancerGaia Griguolo, Maria Vittoria Dieci, Laia Paré, et al.
Pageof 27